Order Article Reprints

Zhu H, Han W, Gan Y, Li Q, Li X, Shao L, Zhu D, Guo H. Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma. Pharmaceutics. 2019; 11(12):683. https://doi.org/10.3390/pharmaceutics11120683

Zhu, Hongyan, Weili Han, Ye Gan, Qiaofeng Li, Xiaolan Li, Lanlan Shao, Dan Zhu, and Hongwei Guo. 2019. "Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma" Pharmaceutics 11, no. 12: 683. https://doi.org/10.3390/pharmaceutics11120683

Zhu, H., Han, W., Gan, Y., Li, Q., Li, X., Shao, L., Zhu, D., & Guo, H. (2019). Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma. Pharmaceutics, 11(12), 683. https://doi.org/10.3390/pharmaceutics11120683